Clinical Trial Update: Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

This is an ongoing Phase 2 trial evaluating adebrelimab with or without SHR-8068 in combination with cisplatin and gemcitabine as first-line therapy for advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• SHR-8068

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Biliary Tract Cancer | Phase 2 | Status: RECRUITING